Array Biopharma Inc (NASDAQ:ARRY)

19.37
Delayed Data
As of Jun 22
 -0.18 / -0.92%
Today’s Change
7.15
Today|||52-Week Range
20.21
+51.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues33.8M29.7M42.2M66.4M
 
 
 
 
 
Cost of Goods Sold9.5M11.2M13.2M17.2M
 
 
 
 
 
Depreciation And Amortization569.0K577.0K561.0K562.0K
 
 
 
 
 
 
Operating ExpensesGross Income23.7M18.0M28.5M48.7M
 
 
 
 
 
General Expenses50.0M53.5M54.2M70.4M
 
 
 
 
 
Research And Development39.1M41.4M42.6M53.6M
 
 
 
 
 
Total Operating Expenses60.1M65.3M67.9M88.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-26.3M-35.5M-25.7M-21.8M
 
 
 
 
 
Extraordinary Credit0.00200.0K0.000.00
 
 
Extraordinary Charge-500.0K0.00-6.8M-100.0K
 
 
 
 
Interest Expense On Debt3.2M3.2M2.8M2.4M
 
 
 
 
 
Other Expenses112.0K0.000.0069.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-29.6M-38.0M-34.1M-22.9M
 
 
 
 
 
Net Income-29.6M-38.0M-34.1M-22.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS170.8M174.8M199.9M209.0M
 
 
 
 
 
Shares To Calculate EPS Diluted170.8M174.8M199.9M209.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.17-$0.22-$0.17-$0.11
 
 
 
 
 
EPS Diluted-$0.17-$0.22-$0.17-$0.11